No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Addition of pembrolizumab to chemotherapy improves survival in patients with advanced esophageal carcinomas

byTeddy Guo

September 30, 2021

in StudyGraphics

Reading Time: 1 min read

Wellness Check: Exercise

RelatedReports

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Oncology

Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer

January 28, 2026

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

The Scan by 2 Minute Medicine®

World Health Organization warns that one in six infections now antibiotic resistant

October 23, 2025

Adalimumab use results in high clinical response rate in hidradenitis suppurativa

All Specialties

Samsung BioLogics lands $1.3 billion U.S. contract amid tariff uncertainty

September 23, 2025

Oncology

Royalty financing deepens exposure to small cell lung cancer revenues

September 8, 2025

$#VisualAbstract Adding uproleselan to chemotherapy in patients with relapsed or refractory acute myeloid leukemia was well-tolerated with high remission rates$

#VisualAbstract Adding uproleselan to chemotherapy in patients with relapsed or refractory acute myeloid leukemia was well-tolerated with high remission rates

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

Contact aspiration with stent retrieval no more effective than stent retrieval alone for thrombectomy revascularization in stroke patients

Earlier puberty associated with increased risk of depression in girls

Placebo effect size in treatment-resistant depression in adults

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports